Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009.DANBURY Danbury (dăn`bĕr'ē, –bərē), city (1990 pop. 65,585), Fairfield co., SW Conn.; settled 1685, inc. as a city 1889. , Conn. -- Biodel Inc. (Nasdaq: BIOD BIOD Built-In Overflow Detection BIOD Block Input Output Daemon ) will issue its fiscal third quarter 2009 financial results on August 7, 2009. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress. August, 2009 schedule: [TABLE OMITTED] Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at http://www.biodel.com. The audio webcast will be archived and available for replay through the website. About Biodel Inc: Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine endocrine /en·do·crine/ (en´do-krin, en´do-krin) 1. secreting internally. 2. pertaining to internal secretions; hormonal. See also under system. en·do·crine adj. disorders, such as diabetes and osteoporosis osteoporosis (ŏs'tēō'pərō`sĭs), disorder in which the normal replenishment of old bone tissue is severely disrupted, resulting in weakened bones and increased risk of fracture; osteopenia . Biodel's product candidates are developed using VIAdel(TM) technology, which reformulates existing FDA-approved peptide peptide, organic compound composed of amino acids linked together chemically by peptide bonds. The peptide bond always involves a single covalent link between the α-carboxyl (oxygen-bearing carbon) of one amino acid and the amino nitrogen of a second amino acid. drugs. For further information regarding Biodel, please visit the company's website at www.Biodel.com. BIOD-G |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion